Navidea Biopharmaceuticals, Inc.

CIK 810509 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Navidea Biopharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Feb 5, 2024SC 13D/A0001104659-24-010817
Jan 31, 2024EFFECT9999999995-24-000255
Jan 31, 2024EFFECT9999999995-24-000259
Jan 31, 2024EFFECT9999999995-24-000253
Jan 31, 2024EFFECT9999999995-24-000254
Jan 31, 2024EFFECT9999999995-24-000252
Jan 26, 2024S-8 POS0001437749-24-002307
Jan 26, 2024S-8 POS0001437749-24-002309
Jan 26, 2024POS AM0001437749-24-002316
Jan 26, 2024POS AM0001437749-24-002314
Jan 26, 2024POS AM0001437749-24-002310
Jan 26, 2024POS AM0001437749-24-002312
Jan 26, 2024S-8 POS0001437749-24-002320
Jan 26, 2024S-8 POS0001437749-24-002315
Jan 26, 2024POS AM0001437749-24-002308
Jan 26, 2024S-8 POS0001437749-24-002317
Jan 26, 2024S-8 POS0001437749-24-002318
Jan 26, 2024S-8 POS0001437749-24-002305
Jan 26, 2024S-8 POS0001437749-24-002313
Jan 26, 2024S-8 POS0001437749-24-002311
Jan 26, 202415-12G0001437749-24-002306
Jan 26, 2024S-8 POS0001437749-24-002319
Jan 16, 202425-NSE0001143313-24-000012
Dec 26, 2023S-80001437749-23-035285
Dec 21, 2023SC 13D/A0001104659-23-128181